SABIC recently announced the official launch of its new US$170 (€157.7) million ultem resin manufacturing facility in Singapore, marking the company’s first advanced specialty chemical manufacturing facility in the region producing the high-performance thermoplastic, ultem resin.
German chemicals, pharmaceuticals and life sciences group Merck, which operates its Healthcare business as EMD Serono in the US and Canada, announced that it plans to move its US Healthcare headquarters, currently located in Rockland, Massachusetts, to Boston’s Seaport district.
Ahead of a change in leadership at the top after the upcoming annual general meeting, in interviews with news agencies Bayer is dropping hints in dribbles about future plans for its healthcare business.
As part of what seems to be a general pattern of staff reductions in the pharmaceutical industry worldwide, a growing number of Western drugmakers are downsizing their sales and marketing presence in India.
As the discussion surrounding the high price of insulin in the US continues unabated, drugmaker Eli Lilly implemented price reductions of 70% for its most commonly prescribed insulin products at the beginning of March.
Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of Alexion in 2021, if it goes ahead. As such, it is under intense scrutiny.
Sanner, a German manufacturer of pharmaceutical primary packaging and medical technology products, is expanding capacity. The company broke ground in January on a new production site and headquarters in Bensheim, as well as on a second manufacturing facility in Kunshan, China, that is due to start up this summer.
In a move to advance productivity, the healthcare division of Germany’s Merck is realigning its drug discovery and launch strategy. Global healthcare research chief Danny Bar-Zohar told a conference call this week that the Darmstadt-based company will seek to strike a new balance between in-house R&D and external collaboration.
LyondellBasell (LYB) said it is moving ahead with engineering for a commercial scale advanced plastics waste recycling plant it intends to build at its Wesseling, Germany, production site together with Germany’s 23 Oaks Investments.
Johnson & Johnson is finally pulling the plug on its iconic talc-based baby powder worldwide.
US conglomerate 3M is to spin off its healthcare business in a move that chairman and CEO Mike Roman said will result in “two well-capitalized, world-class public companies, well positioned to pursue their respective priorities.”
Ineos will build two hand sanitizer plants in the US, adding to the facilities it has already constructed in the UK, Germany and France.
The International Airport Transport Association (IATA) recently awarded the Mumbai and Hyderabad branches of Dachser India with the prestigious CEIV Pharma certification, recognizing the company for its excellence in transporting life science and healthcare (LSH) products.
